Kerala government plans to develop anti-rabies vaccine

Kerala Government is planning to produce anti-rabies vaccine in the state. It will produce the vaccine at the Institute of Animal Health and Veterinary Biologicals (IAH&VB) at Palode near Thiruvananthapuram, under the state Animal Husbandry Department. The institute at present produces viral and bacterial vaccines against cattle and poultry diseases. It plans to produce a total of 10 million doses of both human and animal anti-rabies vaccine. Currently, the state procures vaccine from Hyderabad-based Indian Immunologicals Limited (IIL), a subsidiary of National Dairy Development Board. Read More

India launches new drug for TB

Indian government has launched Bedaquiline, a new anti-TB drug for Drug Resistant TB (DR TB) as part of the Revised National Tuberculosis Control Program (RNTCP). The drug is a new anti-TB drug for treatment of MDR-TB. This new class of drug is a diarylquinoline that specifically targets Mycobacterial ATP synthase, an enzyme essential for supply of energy to Mycobacterium tuberculosis and most other mycobacteria. This drug is indicated for use in the treatment of drug-resistant TB. Bedaquiline is being introduced at six identified tertiary care centres across India. These sites have advanced facilities for laboratory testing and intensive care for patients. Bedaquiline will be given to multi-drug resistant TB patients with resistance to either all fluoroquinolone and/or all second line inj Read More

Kings College Hospital to set up 11 hospitals in India with 11000 beds

King's College Hospital, one of the UK's largest teaching hospitals is planning set up a 1,000-bed world-class medical facility in Andhra Pradesh's new capital Amaravati in Andhra Pradesh. The UK based company is also planning to set up 11 hospitals around India with a capacity of 11000 beds. Indo UK Healthcare, a division of the group is venturing to set up its first hospital in Chandigarh in Haryana. Read More